Triamide-substituted heterobicyclic compounds

Triamide-substituted heterobicyclic compounds

18 The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R-Rare as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lip...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bertinato, Peter, Bronk, Brian S, Blize, Alan E, Cheng, Hengmiao, Li, Jin, Huatan, Hiep, Mason, Clive
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Bertinato, Peter
Bronk, Brian S
Blize, Alan E
Cheng, Hengmiao
Li, Jin
Huatan, Hiep
Mason, Clive
description 18 The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R-Rare as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06949572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06949572</sourcerecordid><originalsourceid>FETCH-uspatents_grants_069495723</originalsourceid><addsrcrecordid>eNrjZNANKcpMzM1MSdUtLk0qLsksKS1JTVHISC1JLcpPykyuTM7JTFZIzs8tyC_NSynmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDM0sTS1NzImAglAARVLBM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Triamide-substituted heterobicyclic compounds</title><source>USPTO Issued Patents</source><creator>Bertinato, Peter ; Bronk, Brian S ; Blize, Alan E ; Cheng, Hengmiao ; Li, Jin ; Huatan, Hiep ; Mason, Clive</creator><creatorcontrib>Bertinato, Peter ; Bronk, Brian S ; Blize, Alan E ; Cheng, Hengmiao ; Li, Jin ; Huatan, Hiep ; Mason, Clive ; Pfizer Inc</creatorcontrib><description>18 The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R-Rare as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.</description><language>eng</language><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6949572$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6949572$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bertinato, Peter</creatorcontrib><creatorcontrib>Bronk, Brian S</creatorcontrib><creatorcontrib>Blize, Alan E</creatorcontrib><creatorcontrib>Cheng, Hengmiao</creatorcontrib><creatorcontrib>Li, Jin</creatorcontrib><creatorcontrib>Huatan, Hiep</creatorcontrib><creatorcontrib>Mason, Clive</creatorcontrib><creatorcontrib>Pfizer Inc</creatorcontrib><title>Triamide-substituted heterobicyclic compounds</title><description>18 The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R-Rare as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZNANKcpMzM1MSdUtLk0qLsksKS1JTVHISC1JLcpPykyuTM7JTFZIzs8tyC_NSynmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDM0sTS1NzImAglAARVLBM</recordid><startdate>20050927</startdate><enddate>20050927</enddate><creator>Bertinato, Peter</creator><creator>Bronk, Brian S</creator><creator>Blize, Alan E</creator><creator>Cheng, Hengmiao</creator><creator>Li, Jin</creator><creator>Huatan, Hiep</creator><creator>Mason, Clive</creator><scope>EFH</scope></search><sort><creationdate>20050927</creationdate><title>Triamide-substituted heterobicyclic compounds</title><author>Bertinato, Peter ; Bronk, Brian S ; Blize, Alan E ; Cheng, Hengmiao ; Li, Jin ; Huatan, Hiep ; Mason, Clive</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_069495723</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Bertinato, Peter</creatorcontrib><creatorcontrib>Bronk, Brian S</creatorcontrib><creatorcontrib>Blize, Alan E</creatorcontrib><creatorcontrib>Cheng, Hengmiao</creatorcontrib><creatorcontrib>Li, Jin</creatorcontrib><creatorcontrib>Huatan, Hiep</creatorcontrib><creatorcontrib>Mason, Clive</creatorcontrib><creatorcontrib>Pfizer Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bertinato, Peter</au><au>Bronk, Brian S</au><au>Blize, Alan E</au><au>Cheng, Hengmiao</au><au>Li, Jin</au><au>Huatan, Hiep</au><au>Mason, Clive</au><aucorp>Pfizer Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Triamide-substituted heterobicyclic compounds</title><date>2005-09-27</date><risdate>2005</risdate><abstract>18 The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R-Rare as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06949572
source USPTO Issued Patents
title Triamide-substituted heterobicyclic compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T08%3A56%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Bertinato,%20Peter&rft.aucorp=Pfizer%20Inc&rft.date=2005-09-27&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06949572%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true